4148 — All Cosmos Bio-Tech Holding Income Statement

0.000.00%

Last trade - 00:00

Basic MaterialsBalancedSmall CapSuper Stock

Annual income statement for All Cosmos Bio-Tech Holding, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	2,197	3,702	2,827	2,459	2,949
Cost of Revenue
Gross Profit	594	1,138	588	669	829
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	1,924	3,035	2,637	2,298	2,652
Operating Profit	273	667	190	161	297
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	322	634	258	253	297
Provision for Income Taxes
Net Income After Taxes	237	456	189	174	206
Minority Interest
Net Income Before Extraordinary Items
Net Income	198	368	139	129	153
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	198	373	151	125	153
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	2.94	5.38	2.03	1.78	2.3
Dividends per Share